BMC Blood Disorders

Executive Editor

Christna Chap, BioMed Central

Editorial Board | Editorial Team | Instructions for authors | FAQ

Articles

There has been an error retrieving the data. Please try again.

Efficacy of intravenous iron treatment

Evidence from the literature suggests that, in line with current recommendations, intravenous ferric carboxymaltose is effective and safe in treating iron deficiency anemia in many chronic conditions, but there are limited trial data comparing different intravenous iron preparations.

BMC Blood Disorders 2011, 11:4

RSS

News from the web

09 February 2012: DVT And PE In Joint Replacement Patients May Be Prevented By Aspirin

08 February 2012: For Atrial Fibrillation Patients At Risk For Stroke, Easy-To-Use Blood Thinners Likely To Replace Coumadin

08 February 2012: Is Economy Class Air Travel Linked To Blood Clot Risk? Apparently Not

Scope

BMC Blood Disorders is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of blood disorders, as well as related molecular genetics, pathophysiology, and epidemiology.

RSS

From the blog

08 February 2012: Invitation to submit to Cancer Bioinformatics thematic series

30 January 2012: BMC-series journals on track for Impact Factor

18 January 2012: Bacterial symbionts – the key to fighting pests and diseases?

Quote

"I strongly believe in the internet and open-access publishing in order to achieve scientific outreach both within academia and outside academia. Open-access allows anyone in the world with access to a computer to access scientific research. These innovative journals are becoming extremely successful and will change the nature of scientific publishing and increase the accessibility of science."

Professor Sally Blower
Semel Institute for Neuroscience & Human Behavior,
UCLA David Geffen School of Medicine, USA